Literature DB >> 27096928

Pityriasis Rosea: A Comprehensive Classification.

Francesco Drago1, Giulia Ciccarese, Alfredo Rebora, Francesco Broccolo, Aurora Parodi.   

Abstract

Pityriasis rosea (PR) is an acute, self-limiting exanthematous disease associated with the endogenous systemic reactivation of human herpesvirus (HHV)-6 and/or HHV-7. The disease typically begins with a single, erythematous plaque followed by a secondary eruption with lesions on the cleavage lines of the trunk (configuration of a 'Christmas tree'). The duration may vary from 2 weeks to a few months. Besides the typical presentation of PR, atypical forms have been described. The previous classifications of PR are mainly based on its atypical morphological features rather than on the pathogenetic mechanisms that underlie the different presentations of the disease. Notably, most of the morphologically atypical forms follow a course amenable to the classic form. The classification that we propose, taking into account the pathogenesis, clinical features, and course of the disease, is easy and intuitive and may be helpful in identifying the atypical forms of PR in order to avoid misdiagnosis and establish the best treatment options. Finally, this classification provides indications for managing potentially harmful forms of PR (such as PR in pregnancy) and PR-like eruptions.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 27096928     DOI: 10.1159/000445375

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  23 in total

1.  Can Unilateral Pityriasis Rosea be Considered a Form of Superimposed Lateralized Exanthem?

Authors:  Francesco Drago; Giulia Ciccarese; Aurora Parodi
Journal:  J Clin Diagn Res       Date:  2017-06-01

2.  Pityriasis rosea-like eruption associated with ondansetron use in pregnancy.

Authors:  Malak M Alame; Dina J Chamsy; Hassan Zaraket
Journal:  Br J Clin Pharmacol       Date:  2018-03-09       Impact factor: 4.335

3.  Isolation of Mayaro Virus from a Venezuelan Patient with Febrile Illness, Arthralgias, and Rash: Further Evidence of Regional Strain Circulation and Possible Long-Term Endemicity.

Authors:  Gabriela M Blohm; Marilianna C Márquez-Colmenarez; John A Lednicky; Tania S Bonny; Carla Mavian; Marco Salemi; Lourdes Delgado-Noguera; John Glenn Morris; Alberto E Paniz-Mondolfi
Journal:  Am J Trop Med Hyg       Date:  2019-12       Impact factor: 2.345

4.  Concurrent pityriasis rosea and Bell's palsy.

Authors:  Vanessa Voss; Adam Mattox; Mary Guo
Journal:  BMJ Case Rep       Date:  2017-01-23

5.  Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine.

Authors:  Olivia G Cohen; Ashley K Clark; Heather Milbar; Mordechai Tarlow
Journal:  Hum Vaccin Immunother       Date:  2021-08-26       Impact factor: 4.526

6.  COVID-19-associated pityriasis rosea in children: Case report and literature review.

Authors:  Maryam Khalili; Bahareh Abtahi-Naeini; Fereshte Rastegarnasab; Kimia Afshar
Journal:  Clin Case Rep       Date:  2022-07-19

7.  Impact of COVID-19 on Clinicopathological Spectrum of Pityriasis Rosea in Korea.

Authors:  Dai Hyun Kim; Jun Hyuk Cho; Sung Jin Park; Soo Hong Seo; Hyo Hyun Ahn
Journal:  J Korean Med Sci       Date:  2022-06-20       Impact factor: 5.354

8.  Pityriasis rosea and pityriasis rosea-like eruptions after COVID-19 vaccines.

Authors:  Francesco Drago; Giulia Ciccarese; Aurora Parodi
Journal:  JAAD Int       Date:  2022-05-03

9.  Follow-up of skin lesions during the evolution of COVID-19: a case report.

Authors:  Vanessa Lucilia Silveira de Medeiros; Lucas Fagundes Teixeira Silva
Journal:  Arch Dermatol Res       Date:  2020-05-14       Impact factor: 3.033

10.  Biophysical and ultrasonographic changes in pityriasis rosea compared with uninvolved skin.

Authors:  Taraneh Yazdanparast; Kamran Yazdani; Saman Ahmad Nasrollahi; Leila Izadi Firouzabadi; Philippe Humbert; Alireza Khatami; Alireza Firooz
Journal:  Int J Womens Dermatol       Date:  2020-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.